Synthesis and evaluation of bi-functional 7-Hydroxycoumarin (cas 93-35-6) platinum(IV) complexes as antitumor agents

Add time:07/16/2019    Source:sciencedirect.com

A series of bi-functional 7-Hydroxycoumarin (cas 93-35-6) platinum(IV) complexes were synthesized, characterized, and evaluated for antitumor activities. The 7-hydroxycoumarin platinum(IV) complexes display moderate to effective antitumor activities toward the tested cell lines and show much potential in overcoming drug resistance of platinum(II) drugs. In reducing microenvironment, the title compounds could be reduced to platinum(II) complex accompanied with two equivalents of coumarin units. By a unique mechanism, the 7-hydroxycoumarin platinum(IV) complex attacks DNA via the released platinum(II) compound, meanwhile it also inhibits the activities of cyclooxygenase by coumarin fragment. This action mechanism might be of much benefit for reducing tumor-related inflammation in the progress of inhibiting tumor proliferation and overcoming cisplatin resistance. The incorporation of 7-hydroxycoumarin leads to significantly enhanced platinum accumulation in both whole tumor cells and DNA. The HSA interaction investigation reveals that the tested coumarin platinum(IV) compound could effectively combine with HSA via van der Waals force and hydrogen bond.

We also recommend Trading Suppliers and Manufacturers of 7-Hydroxycoumarin (cas 93-35-6). Pls Click Website Link as below: cas 93-35-6 suppliers

Prev:Inhibition of human cytochrome P450 2A6 by 7-Hydroxycoumarin (cas 93-35-6) analogues: Analysis of the structure-activity relationship and isoform selectivity
Next:Structural investigation of Cu(II) complexes with dibromo 7-Hydroxycoumarin (cas 93-35-6) derivatives using methodology based on XAS)